CT radiomics based on different machine learning models for classifying gross tumor volume and normal liver tissue in hepatocellular carcinoma

Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited...

Full description

Saved in:
Bibliographic Details
Published inCancer imaging Vol. 24; no. 1; pp. 20 - 9
Main Authors Zhang, Huai-wen, Huang, De-long, Wang, Yi-ren, Zhong, Hao-shu, Pang, Hao-wen
Format Journal Article
LanguageEnglish
Published London BioMed Central 26.01.2024
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1470-7330
1740-5025
1470-7330
DOI10.1186/s40644-024-00652-4

Cover

Abstract Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Results Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). Conclusion CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.
AbstractList Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Results Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). Conclusion CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.
Background & aimsThe present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.MethodsWe recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.ResultsSeven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).ConclusionCT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.
The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.
Abstract Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Results Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). Conclusion CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.
The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.
Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Results Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). Conclusion CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. Keywords: CT radiomics, Hepatocellular carcinoma, Automatic classification, Machine learning
The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.BACKGROUND & AIMSThe present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.METHODSWe recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).RESULTSSeven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.CONCLUSIONCT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.
ArticleNumber 20
Audience Academic
Author Zhang, Huai-wen
Wang, Yi-ren
Huang, De-long
Zhong, Hao-shu
Pang, Hao-wen
Author_xml – sequence: 1
  givenname: Huai-wen
  surname: Zhang
  fullname: Zhang, Huai-wen
  organization: Department of Radiotherapy, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, Department of Oncology, The third people’s hospital of Jingdezhen, The third people’s hospital of Jingdezhen affiliated to Nanchang Medical College
– sequence: 2
  givenname: De-long
  surname: Huang
  fullname: Huang, De-long
  organization: School of Clinical Medicine, Southwest Medical University
– sequence: 3
  givenname: Yi-ren
  surname: Wang
  fullname: Wang, Yi-ren
  organization: School of Nursing, Southwest Medical University
– sequence: 4
  givenname: Hao-shu
  surname: Zhong
  fullname: Zhong, Hao-shu
  email: 164678062@qq.com
  organization: Department of Hematology, Huashan Hospital, Fudan University
– sequence: 5
  givenname: Hao-wen
  surname: Pang
  fullname: Pang, Hao-wen
  email: haowenpang@foxmail.com
  organization: Department of Oncology, The Affiliated Hospital of Southwest Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38279133$$D View this record in MEDLINE/PubMed
BookMark eNp9ktlq3DAUhk1JaZb2BXpRBIXSG6eSLMvyZRi6BAK9Sa_FsZYZDbI0lexAXqLPXHkmaRZKEELi8P2_lvOfVkchBlNV7wk-J0TwL5lhzliNaZmYt7Rmr6oTwjpcd02Djx7tj6vTnLcY01703ZvquBG060nTnFR_VtcogXZxdCqjAbLRKAaknbUmmTChEdTGBYO8gRRcWKMxauMzsjEh5SFnZ2-X8jrFnNE0j6V-E_08GgRBoxDTCB55d2MSmlzOs0EuoI3ZwRSV8X72UIwgKRfiCG-r1xZ8Nu_u1rPq17ev16sf9dXP75eri6tataKZaq1ahYFqa6jg2rZCMdBcQceZNoy1oAZoKGstZ0QDJUIQ24nBDrThWoNtzqrLg6-OsJW75EZItzKCk_tCTGsJaXLKG8lp17RGYUoAM9sOA9GD4BQPg9XFlRavzwevXYq_Z5MnObq8PA2CiXOWtCd9xzDGbUE_PkO3cU6hvLRQtOUc90Q8UGso57tg45RALabyohO0uNH9sef_ocrQpvSyJMW6Un8i-PRIsDHgp00unZpcDPkp-OHulvMwGv3ve-5TUwBxANTS9GSsVG6CxadcwXlJsFwCKg8BlSWgch9QyYqUPpPeu78oag6iXOCwNunh215Q_QWWdvgS
CitedBy_id crossref_primary_10_1016_j_engappai_2024_109452
crossref_primary_10_33192_smj_v77i2_271596
crossref_primary_10_1016_j_ejro_2024_100615
crossref_primary_10_3389_fonc_2024_1411214
crossref_primary_10_1186_s12885_024_13235_0
crossref_primary_10_1088_1361_6560_ad3cb1
crossref_primary_10_20935_AcadMed7444
crossref_primary_10_3390_cancers16061158
Cites_doi 10.1016/j.ejmp.2021.05.009
10.1109/JTEHM.2019.2915534
10.3389/fonc.2022.650797
10.1038/s41598-020-63285-0
10.1109/MSP.2014.2347059
10.3389/fonc.2020.01621
10.1002/acm2.13024
10.1038/s41420-021-00634-6
10.1016/j.media.2021.102154
10.1002/mp.12602
10.1016/j.ejca.2011.11.036
10.1016/j.hpb.2019.11.002
10.1109/TPAMI.2016.2572683
10.1007/s00330-021-07877-y
10.1634/theoncologist.2019-IO-S1-s01
10.1007/s002689900215
10.1186/s13014-019-1392-z
10.1118/1.4871620
10.1007/s00330-020-06957-9
10.1002/mp.14320
10.1109/TIP.2019.2902784
10.1007/s00330-020-07641-8
10.3322/caac.21660
10.2174/1573405615666190503142031
10.1109/34.216733
10.1007/s00330-018-5787-2
10.1148/radiol.2017170554
10.1158/1078-0432.CCR-16-0460
10.1023/A:1011174803800
10.1111/apt.16563
10.3390/cancers14112798
10.1016/j.radonc.2021.03.030
10.1371/journal.pone.0205003
10.1002/bjs.5278
10.1002/mp.14131
10.3389/fmedt.2021.767836
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88C
88E
8FE
8FG
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
HCIFZ
K9.
M0S
M0T
M1P
P5Z
P62
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
DOA
DOI 10.1186/s40644-024-00652-4
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Central
ProQuest Technology Collection
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Healthcare Administration Database
Medical Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DOAJ (Directory of Open Access Journals)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest One Academic Eastern Edition
ProQuest Health Management
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Advanced Technologies & Aerospace Database
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
PubMed




MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1470-7330
EndPage 9
ExternalDocumentID oai_doaj_org_article_62735ec021a04f5bb1db8620bbfd1f72
A782197272
38279133
10_1186_s40644_024_00652_4
Genre Journal Article
GrantInformation_xml – fundername: The Sichuan Provincial Medical Research Project Plan
  grantid: S21004
– fundername: The Open Fund for Scientific Research of Jiangxi Cancer Hospital
  grantid: 2021J15
GroupedDBID ---
0R~
1.S
29B
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FE
8FG
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFO
ACGFS
ACIHN
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AQUVI
ARAPS
ASPBG
AVWKF
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M0T
M1P
M48
OK1
P2P
P62
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
ROL
RPM
RSV
SOJ
SV3
TR2
UKHRP
WOQ
AAYXX
ALIPV
CITATION
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c583t-dc5c0a2dfe286df58c4ad6ca764de445acba3245f641da21881f78bfb236ddaf3
IEDL.DBID M48
ISSN 1470-7330
1740-5025
IngestDate Wed Aug 27 01:20:07 EDT 2025
Thu Sep 04 20:20:19 EDT 2025
Sat Jul 26 00:14:25 EDT 2025
Tue Jun 17 22:25:43 EDT 2025
Tue Jun 10 21:14:00 EDT 2025
Thu May 22 21:20:55 EDT 2025
Thu Apr 03 06:58:56 EDT 2025
Tue Jul 01 04:33:57 EDT 2025
Thu Apr 24 23:13:32 EDT 2025
Sat Sep 06 07:22:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hepatocellular carcinoma
Automatic classification
CT radiomics
Machine learning
Language English
License 2024. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c583t-dc5c0a2dfe286df58c4ad6ca764de445acba3245f641da21881f78bfb236ddaf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2925660918?pq-origsite=%requestingapplication%
PMID 38279133
PQID 2925660918
PQPubID 2040154
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_62735ec021a04f5bb1db8620bbfd1f72
proquest_miscellaneous_2919740005
proquest_journals_2925660918
gale_infotracmisc_A782197272
gale_infotracacademiconefile_A782197272
gale_healthsolutions_A782197272
pubmed_primary_38279133
crossref_citationtrail_10_1186_s40644_024_00652_4
crossref_primary_10_1186_s40644_024_00652_4
springer_journals_10_1186_s40644_024_00652_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-26
PublicationDateYYYYMMDD 2024-01-26
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-26
  day: 26
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cancer imaging
PublicationTitleAbbrev Cancer Imaging
PublicationTitleAlternate Cancer Imaging
PublicationYear 2024
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References P Brodt (652_CR2) 2016; 22
CA Owens (652_CR33) 2018; 13
W Zhu (652_CR8) 2021; 7
N Maffei (652_CR34) 2021; 83
A Tang (652_CR18) 2018; 286
H Sung (652_CR1) 2021; 71
SH Ahn (652_CR29) 2019; 14
H Kim (652_CR13) 2020; 10
G Sharp (652_CR12) 2014; 41
A Rowcroft (652_CR4) 2020; 22
652_CR20
F Leymarie (652_CR9) 1993; 15
W Liu (652_CR11) 2019; 28
652_CR19
652_CR16
X Zhao (652_CR24) 2022; 12
D Zhang (652_CR35) 2020; 21
C Sperti (652_CR5) 1997; 21
T Vrtovec (652_CR30) 2020; 47
M Aloudat (652_CR10) 2019; 7
I Fornacon-Wood (652_CR27) 2020; 30
E Shelhamer (652_CR14) 2017; 39
E Chakraborty (652_CR7) 2022; 14
X Zhang (652_CR31) 2020; 10
A Hubert Beaumont (652_CR21) 2021; 31
MB Tayel (652_CR25) 2020; 16
X Liu (652_CR6) 2019; 24
R Mohammadi (652_CR28) 2021; 159
Z Peng (652_CR15) 2020; 47
P Lambin (652_CR17) 2012; 48
D Luo (652_CR26) 2021; 3
E Harding-Theobald (652_CR22) 2021; 54
J Zhao (652_CR23) 2021; 73
K Men (652_CR36) 2017; 44
VM Patel (652_CR32) 2015; 32
J Leporrier (652_CR3) 2006; 93
References_xml – volume: 83
  start-page: 278
  year: 2021
  ident: 652_CR34
  publication-title: Phys Med
  doi: 10.1016/j.ejmp.2021.05.009
– volume: 7
  start-page: 1
  year: 2019
  ident: 652_CR10
  publication-title: IEEE J Translational Eng Health Med
  doi: 10.1109/JTEHM.2019.2915534
– volume: 12
  start-page: 650797
  year: 2022
  ident: 652_CR24
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.650797
– volume: 10
  start-page: 6204
  issue: 1
  year: 2020
  ident: 652_CR13
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-63285-0
– volume: 32
  start-page: 53
  issue: 3
  year: 2015
  ident: 652_CR32
  publication-title: IEEE Signal Process Mag
  doi: 10.1109/MSP.2014.2347059
– volume: 10
  start-page: 1621
  year: 2020
  ident: 652_CR31
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.01621
– volume: 21
  start-page: 158
  issue: 10
  year: 2020
  ident: 652_CR35
  publication-title: J Appl Clin Med Phys
  doi: 10.1002/acm2.13024
– volume: 7
  start-page: 244
  issue: 1
  year: 2021
  ident: 652_CR8
  publication-title: Cell Death Discov
  doi: 10.1038/s41420-021-00634-6
– volume: 73
  start-page: 102154
  year: 2021
  ident: 652_CR23
  publication-title: Med Image Anal
  doi: 10.1016/j.media.2021.102154
– volume: 44
  start-page: 6377
  issue: 12
  year: 2017
  ident: 652_CR36
  publication-title: Med Phys
  doi: 10.1002/mp.12602
– volume: 48
  start-page: 441
  issue: 4
  year: 2012
  ident: 652_CR17
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2011.11.036
– volume: 22
  start-page: 497
  issue: 4
  year: 2020
  ident: 652_CR4
  publication-title: HPB (Oxford)
  doi: 10.1016/j.hpb.2019.11.002
– volume: 39
  start-page: 640
  issue: 4
  year: 2017
  ident: 652_CR14
  publication-title: IEEE Trans Pattern Anal Mach Intell
  doi: 10.1109/TPAMI.2016.2572683
– ident: 652_CR20
  doi: 10.1007/s00330-021-07877-y
– volume: 24
  start-page: 3
  issue: Suppl 1
  year: 2019
  ident: 652_CR6
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2019-IO-S1-s01
– volume: 21
  start-page: 195
  issue: 2
  year: 1997
  ident: 652_CR5
  publication-title: World J Surg
  doi: 10.1007/s002689900215
– volume: 14
  start-page: 213
  issue: 1
  year: 2019
  ident: 652_CR29
  publication-title: Radiat Oncol
  doi: 10.1186/s13014-019-1392-z
– volume: 41
  start-page: 050902
  issue: 5
  year: 2014
  ident: 652_CR12
  publication-title: Med Phys
  doi: 10.1118/1.4871620
– volume: 30
  start-page: 6241
  issue: 11
  year: 2020
  ident: 652_CR27
  publication-title: Eur Radiol
  doi: 10.1007/s00330-020-06957-9
– volume: 47
  start-page: e929
  issue: 9
  year: 2020
  ident: 652_CR30
  publication-title: Med Phys
  doi: 10.1002/mp.14320
– volume: 28
  start-page: 3766
  issue: 8
  year: 2019
  ident: 652_CR11
  publication-title: IEEE Trans Image Process
  doi: 10.1109/TIP.2019.2902784
– volume: 31
  start-page: 6059
  issue: 8
  year: 2021
  ident: 652_CR21
  publication-title: Eur Radiol
  doi: 10.1007/s00330-020-07641-8
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 652_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 16
  start-page: 611
  issue: 5
  year: 2020
  ident: 652_CR25
  publication-title: Curr Med Imaging
  doi: 10.2174/1573405615666190503142031
– volume: 15
  start-page: 617
  issue: 6
  year: 1993
  ident: 652_CR9
  publication-title: IEEE Trans Pattern Anal Mach Intell
  doi: 10.1109/34.216733
– ident: 652_CR19
  doi: 10.1007/s00330-018-5787-2
– volume: 286
  start-page: 29
  issue: 1
  year: 2018
  ident: 652_CR18
  publication-title: Radiology
  doi: 10.1148/radiol.2017170554
– volume: 22
  start-page: 5971
  issue: 24
  year: 2016
  ident: 652_CR2
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-0460
– ident: 652_CR16
  doi: 10.1023/A:1011174803800
– volume: 54
  start-page: 890
  issue: 7
  year: 2021
  ident: 652_CR22
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.16563
– volume: 14
  start-page: 2798
  issue: 11
  year: 2022
  ident: 652_CR7
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers14112798
– volume: 159
  start-page: 231
  year: 2021
  ident: 652_CR28
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2021.03.030
– volume: 13
  start-page: e0205003
  issue: 10
  year: 2018
  ident: 652_CR33
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0205003
– volume: 93
  start-page: 465
  issue: 4
  year: 2006
  ident: 652_CR3
  publication-title: Br J Surg
  doi: 10.1002/bjs.5278
– volume: 47
  start-page: 2526
  issue: 6
  year: 2020
  ident: 652_CR15
  publication-title: Med Phys
  doi: 10.1002/mp.14131
– volume: 3
  start-page: 767836
  year: 2021
  ident: 652_CR26
  publication-title: Front Med Technol
  doi: 10.3389/fmedt.2021.767836
SSID ssj0029897
Score 2.404275
Snippet Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in...
The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular...
Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in...
Background & aimsThe present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in...
Abstract Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver...
SourceID doaj
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 20
SubjectTerms Accuracy
Algorithms
Automatic classification
Calibration
Cancer Research
Chemotherapy
Classification
Computed tomography
Correlation coefficients
CT imaging
CT radiomics
Data mining
Deep learning
Diagnostic imaging
Diagnostic systems
Discrimination
Hepatocellular carcinoma
Hepatoma
Imaging
Liver
Liver cancer
Machine learning
Medical imaging
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Nuclear Medicine
Oncology
Patients
Radiology
Radiomics
Regression
Research Article
Software
Statistical analysis
Support vector machines
Tumors
SummonAdditionalLinks – databaseName: DOAJ (Directory of Open Access Journals)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gBSMhcQCrediOfSwVVYVUTq3Um-VnWWk3qbrZv8Fv7oyTLF0QcOGaTKJkZjzf52QehLxvsa-U14HxGGCDkprAHGyEmJMhaBGVdAFrh8--ydML_vVSXN4Z9YU5YWN74FFxhxLwVUQPUGRLnoRzVXDAwkvnUqhSm6Nvqct5MzVttbTS7Vwio-ThGmCLcwZ4xBBza8Z3YCh36_89Jt8BpV_-kmbwOXlEHk6skR6NT_uY3IvdE3L_bPov_pT8OD6nNzYssMR4TRGZAu07Ok8_Gegq50xGOg2JuKJ5As6aAmWlHgn0Itc70St8WjpsVnB8DFzUdoF2yGyXdIlJHHTItqKLjn4HLBt6_PaPyazU41yirl_ZZ-Ti5Mv58SmbJi0wL1QzsOCFL20dUqyVDEkoz22Q3raSh8i5sN5ZYF4iSV4FC6xAgeqVS65uwKY2Nc_JXtd38SWhMsXEW6m9jg0Xdat943xSwBur0rZBF6SaFW_81IYcp2EsTd6OKGlGYxkwlsnGMrwgH7fXXI9NOP4q_RntuZXEBtr5ALiVmdzK_MutCvIWvcGM1ajbMGCOgFHhpDaU-JAlMBDAC3g71TOAGrCl1o7k_o4kLGC_e3r2ODMFkLWpNXBRCWROFeTd9jReiUlxXew3KAM34Mi6C_Ji9NTtSzcKVF81TUE-za778-Z_1t2r_6G71-RBnZdaxWq5T_aGm008AOo2uDd5ld4ChBc_Zg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2ggJGQOIDVTeI4zgmViqVCKqdW6s3yc1lpNym72b_Bb2bGcVIWRK_JJIo9nvk-x_Mg5F2NdaVs4xj3DjYooXTMwEaIGeFcU3kpjMPc4bPv4vSCf7usLtMPt20Kqxx9YnTUrrP4j_yoaACcBaCb_HT1k2HXKDxdTS00bpM7eQFYi5ni86_ThquRQ3OVms9YBeA-Js1IcbQFIOOcAUIxROGC8T1givX7__XSf8DUX-emEY7mD8j9xCPp8aD4h-SWbx-Ru2fppPwx-XVyTjfaLTHpeEsRqxztWjr2Q-npOkZRepraRixo7ImzpUBiqUVKvYwZUHSBX0v73RquD66M6tbRFrnuiq4wrIP2UXt02dIfgG59h6cBGN5KLXYqaru1fkIu5l_OT05Z6r3AbCXLnjlb2ZkuXPCFFC5U0nLthNW14M5zXmlrNHCxKgieOw08QeahliaYogQt61A-JQdt1_rnhIrgA69FYxtf8qqoG1saGyQwyXyma9dkJB8nXtlUmBz7Y6xU3KBIoQZlKVCWispSPCMfpmeuhrIcN0p_Rn1OklhSO17oNguVLFQJIHKVt8B59IyHypjcGdjuzYwJDsZWZOQNrgY15KdOjkEdA8fC3m0o8T5KoGuAAVidMhxgGrDI1p7k4Z4kmLTdvz2uOJVcylZdG0BG3k638UkMk2t9t0MZeAFHHp6RZ8NKnQZdSpj6vCwz8nFcutcv___cvbj5W16Se0U0opwV4pAc9JudfwU0rTevoy3-BiT0OHs
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9QwDI5gkRAXxJvCAkZC4gAV0zZJ0-MyYrVCWk670t6iPJeRZlq00_kb_Gbs9MEOL4lr4kRNbMefm9hm7E1NeaVc43MePDoosfK5RUcot9L7RgQlrafY4dMv8uScf74QF2OaHIqFuX5_Xyj5YYsGh_McLUlO1rLM-U12S-DBS9K8lMvZuWpUU09BMX8ct2d4Un7-30_ha2bol3vRZG6O77G7I06Eo4Gx99mN0D5gt0_Hm_CH7PvyDK6MX1FQ8RbIFnnoWpjqnfSwSa8kA4xlIS4h1bzZAoJUcASZVynCCS7pa6HfbbB9OKrAtB5awrJrWNOzDegTd2DVwle0Xn1Hf_vp-So4qkTUdhvziJ0ffzpbnuRjbYXcCVX1uXfCLUzpYyiV9FEox42XztSS-8C5MM4axFoiSl54gzhAFbFWNtqyQi6aWD1mB23XhqcMZAyR17JxTai4KOvGVdZFhUixWJjaNxkrpo3Xbkw8TvUv1jo5IErqgVkamaUTszTP2Lt5zLch7cY_qT8SP2dKSpmdGlCS9KiBWiJQE8EhpjELHoW1hbfozi2sjR7XVmbsFUmDHuJPZ8XXR4ihqDYbUbxNFKT6uABnxggG3AZKorVHebhHiSrr9rsnidPjkbHVZYPoUyJ8Uxl7PXfTSHoG14ZuRzQ4ASecnbEng6TOi64Ubn1RVRl7P4nuz8n_vnfP_o_8ObtTJqUq8lIesoP-ahdeICzr7cukjz8At0Yvaw
  priority: 102
  providerName: Springer Nature
Title CT radiomics based on different machine learning models for classifying gross tumor volume and normal liver tissue in hepatocellular carcinoma
URI https://link.springer.com/article/10.1186/s40644-024-00652-4
https://www.ncbi.nlm.nih.gov/pubmed/38279133
https://www.proquest.com/docview/2925660918
https://www.proquest.com/docview/2919740005
https://doaj.org/article/62735ec021a04f5bb1db8620bbfd1f72
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ri9NAEF_uAeIX8W31rCsIftBok2w2mw8id-XqIdwhcoV-W_ZZC22ibQr6T_g3O7N5aPUUvwSSTJbuzszOb7rzIORZjnWlTGEj5iw4KD61kQZHKNLc2iJzgmuLucPnF_xsyt7Pstke6dodtQu4udK1w35S0_Xy1dcv396Cwr8JCi_46w0YJcYisDYRWtQkYvvkMJwXYSgf608VsNh4aLbC8lGUgyPfJdFcOcaOoQr1_P_ctX8xW7-dowbzNLlJbrS4kh43gnCL7LnyNrl23p6c3yHfx5d0rewCk5A3FG2XpVVJu_4oNV2FqEpH2zYScxp65GwogFpqEGIvQkYUneOvpfV2Bc-brY2q0tISse-SLjHMg9aBm3RR0k9g7eoKTwcw3JUa7FxUVit1l0wnp5fjs6jtxRCZTKR1ZE1mRiqx3iWCW58Jw5TlRuWcWcdYpoxWgM0yz1lsFeAGEftcaK-TFLiufHqPHJRV6R4Qyr3zLOeFKVzKsiQvTKqNF4As45HKbTEgcbfw0rSFyrFfxlIGh0Vw2TBLArNkYJZkA_Ki_-ZzU6bjn9QnyM-eEktshwfVei5bjZUcgF3mDGAgNWI-0zq2Gty_kdbewtySAXmC0iCbfNV-o5DHgLmwlxtSPA8UKLwwAaPajAdYBiy6tUN5tEMJKm52X3cSJzsNkUkBaJUD3BMD8rR_jV9i2Fzpqi3SwAAMcfmA3G8ktZ90KmDp4zQdkJed6P4c_O9r9_C_J_WIXE-CPsVRwo_IQb3euseA4Go9JPv5LIermLwbksOT04sPH-FuzMfD8J_IMKjtD0ybRPI
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH8KgxkJxANYaxLHcR4QGoOpY-ueOqlvxv9SJrXJaFMhvgQfhc_InZO0FMTe9ppcLNt3vt_vYp-PkJcZ3itlc8e4dxCgFIljBgIhZoRzeeqlMA5zh4enYnDGP4_T8Rb51eXC4LHKzicGR-0qi__I9-IcwFkAusn3F98YVo3C3dWuhEZjFsf-x3cI2Rbvjj6Cfl_F8eGn0cGAtVUFmE1lUjNnU9vXsSt8LIUrUmm5dsLqTHDnOU-1NRpYRloIHjkNCCijIpOmMHEC_ddFAu1eI9c5bjHC-snG6wAvl00xl4z3WQpkokvSkWJvAcDJOQNEZIj6MeMbQBjqBfyLCn_A4l_7tAH-Du-Q2y1vpfuNod0lW768R24M2535--TnwYjOtTvHJOcFRWx0tCppV3-lprNwatPTtkzFhIYaPAsKpJlapPDnIeOKTrC3tF7O4HnjOqkuHS2RW0_pFI-R0DpYCz0v6VdA07rC3Qc8TkstVkYqq5l-QM6uRCsPyXZZlf4xoaLwBc9EbnOf8DTOcpsYW0hgrlFfZy7vkaibeGXbi9CxHsdUhYBICtUoS4GyVFCW4j3yZvXNRXMNyKXSH1CfK0m8wjs8qOYT1XoEJYA4pt4Cx9J9XqTGRM5AeNk3pnAwtrhHdtEaVJMPu3JEah84HdaKQ4nXQQJdEQzA6jajAqYBL_XakNzZkAQXYjdfdxanWhe2UOsF1yMvVq_xSzyWV_pqiTLQAEfe3yOPGktdDTqRMPVRkvTI2850143_f-6eXN6XXXJzMBqeqJOj0-On5FYcFlTEYrFDtuv50j8Dilib52FdUvLlqh3Bb2iCd7k
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9QwELaglSpeUDkbWqiRkHiAqJvEcZzHpbAqC62QaKW-WT6XlXaTajf7N_jNzDgHXS6J13hsxR7PzDfyHIS8KrCulCltzJwFB8VnNtbgCMWaW1vmTnBtMXf4_IKfXbHpdX59K4s_RLv3T5JtTgNWaaqakxvrWxEX_GQNZoixGOxLjDY0jdldsivysgT3a3c8nn6dDk5XKcqiT5b548wtgxTq9v-unW-Zp1_eS4MZmuyT-x1-pOOW4Q_IHVc9JHvn3Qv5I_L99JKulJ1jsvGaoo2ytK5o3welocsQPelo1y5iRkMvnDUF8EoNQul5yHyiM_xb2myW8L1VYVRVllaIcRd0geEctAlco_OKfgOr1tT4CoBhrdRgh6KqXqrH5Gry4fL0LO56LsQmF1kTW5ObkUqtd6ng1ufCMGW5UQVn1jGWK6MVYLDcc5ZYBfhAJL4Q2us0A-4qnz0hO1VduQNCuXeeFbw0pctYnhalybTxAhBkMlKFLSOS9AcvTVeQHPtiLGRwTASXLbMkMEsGZkkWkTfDnJu2HMc_qd8hPwdKLKUdPtSrmewkU3IAcLkzgHXUiPlc68RqcPNGWnsLe0sjcoy3QbZ5qYNCkGPAVtizDSleBwpUCbABo7rMBjgGLK61RXm0RQmibLaH-xsnO1WylmkJqJQDrBMReTkM40wMj6tcvUEaWIAh_o7I0_amDpvOBBx9kmURedtf3Z-L__3snv0f-THZ-_J-Ij9_vPh0SO6lQb6SOOVHZKdZbdxzQG6NftEJ5w8FETwY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CT+radiomics+based+on+different+machine+learning+models+for+classifying+gross+tumor+volume+and+normal+liver+tissue+in+hepatocellular+carcinoma&rft.jtitle=Cancer+imaging&rft.au=Zhang%2C+Huai-wen&rft.au=Huang%2C+De-long&rft.au=Wang%2C+Yi-ren&rft.au=Zhong%2C+Hao-shu&rft.date=2024-01-26&rft.pub=BioMed+Central+Ltd&rft.issn=1470-7330&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs40644-024-00652-4&rft.externalDocID=A782197272
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1470-7330&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1470-7330&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1470-7330&client=summon